Zhu, Yanping
Liu, Ta-Wei
Cecioni, Samy
Eskandari, Razieh
Zandberg, Wesley F
Vocadlo, David J http://orcid.org/0000-0001-6897-5558
Article History
Received: 21 December 2014
Accepted: 13 February 2015
First Online: 16 March 2015
Competing interests
: D.J.V. is a cofounder of Alectos Therapeutics, a company involved in the development of OGA modulators for the treatment of Alzheimer's disease. D.J.V. serves as CSO and chair of the Scientific Advisory Board of Alectos Therapeutics.